nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A43—Dexamethasone—hematologic cancer	0.071	0.1	CbGbCtD
Ethosuximide—CYP2E1—Thalidomide—hematologic cancer	0.0289	0.0408	CbGbCtD
Ethosuximide—CYP3A7—Ifosfamide—hematologic cancer	0.0263	0.0372	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0263	0.0372	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0252	0.0355	CbGbCtD
Ethosuximide—CYP3A7—Imatinib—hematologic cancer	0.0252	0.0355	CbGbCtD
Ethosuximide—CYP2E1—Dacarbazine—hematologic cancer	0.0248	0.0351	CbGbCtD
Ethosuximide—CYP3A5—Daunorubicin—hematologic cancer	0.0246	0.0348	CbGbCtD
Ethosuximide—CYP3A5—Thalidomide—hematologic cancer	0.0224	0.0317	CbGbCtD
Ethosuximide—CYP3A5—Teniposide—hematologic cancer	0.0214	0.0302	CbGbCtD
Ethosuximide—CYP3A5—Ifosfamide—hematologic cancer	0.0198	0.0279	CbGbCtD
Ethosuximide—CYP2E1—Mitoxantrone—hematologic cancer	0.0193	0.0272	CbGbCtD
Ethosuximide—CYP3A5—Imatinib—hematologic cancer	0.0189	0.0267	CbGbCtD
Ethosuximide—CYP3A4—Bexarotene—hematologic cancer	0.0164	0.0232	CbGbCtD
Ethosuximide—CYP3A7—Irinotecan—hematologic cancer	0.0157	0.0222	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0157	0.0222	CbGbCtD
Ethosuximide—CYP3A4—Lomustine—hematologic cancer	0.0152	0.0215	CbGbCtD
Ethosuximide—CYP3A4—Busulfan—hematologic cancer	0.0152	0.0215	CbGbCtD
Ethosuximide—CYP3A5—Dasatinib—hematologic cancer	0.0152	0.0214	CbGbCtD
Ethosuximide—CYP3A7—Vincristine—hematologic cancer	0.0137	0.0194	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0137	0.0194	CbGbCtD
Ethosuximide—CYP3A4—Thiotepa—hematologic cancer	0.0136	0.0192	CbGbCtD
Ethosuximide—CYP2E1—Etoposide—hematologic cancer	0.0122	0.0172	CbGbCtD
Ethosuximide—CYP3A5—Irinotecan—hematologic cancer	0.0118	0.0167	CbGbCtD
Ethosuximide—CYP3A4—Methoxsalen—hematologic cancer	0.0106	0.0149	CbGbCtD
Ethosuximide—CYP3A7—Dexamethasone—hematologic cancer	0.0103	0.0146	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.0103	0.0146	CbGbCtD
Ethosuximide—CYP3A5—Vincristine—hematologic cancer	0.0103	0.0146	CbGbCtD
Ethosuximide—CYP3A4—Bortezomib—hematologic cancer	0.01	0.0142	CbGbCtD
Ethosuximide—CYP2E1—Dexamethasone—hematologic cancer	0.00999	0.0141	CbGbCtD
Ethosuximide—CYP3A4—Daunorubicin—hematologic cancer	0.00961	0.0136	CbGbCtD
Ethosuximide—CYP3A5—Etoposide—hematologic cancer	0.00944	0.0133	CbGbCtD
Ethosuximide—CYP3A4—Cytarabine—hematologic cancer	0.00847	0.012	CbGbCtD
Ethosuximide—CYP3A4—Teniposide—hematologic cancer	0.00835	0.0118	CbGbCtD
Ethosuximide—CYP3A5—Dexamethasone—hematologic cancer	0.00776	0.011	CbGbCtD
Ethosuximide—CYP3A4—Ifosfamide—hematologic cancer	0.0077	0.0109	CbGbCtD
Ethosuximide—CYP3A4—Imatinib—hematologic cancer	0.00736	0.0104	CbGbCtD
Ethosuximide—CYP3A4—Ruxolitinib—hematologic cancer	0.00693	0.00979	CbGbCtD
Ethosuximide—CYP3A4—Nilotinib—hematologic cancer	0.00669	0.00945	CbGbCtD
Ethosuximide—CYP3A4—Vinorelbine—hematologic cancer	0.00663	0.00937	CbGbCtD
Ethosuximide—CYP3A4—Triamcinolone—hematologic cancer	0.00607	0.00857	CbGbCtD
Ethosuximide—CYP3A4—Dasatinib—hematologic cancer	0.00591	0.00835	CbGbCtD
Ethosuximide—CYP3A4—Mitoxantrone—hematologic cancer	0.00584	0.00825	CbGbCtD
Ethosuximide—CYP3A4—Betamethasone—hematologic cancer	0.0052	0.00735	CbGbCtD
Ethosuximide—CYP3A4—Prednisolone—hematologic cancer	0.00513	0.00725	CbGbCtD
Ethosuximide—CYP3A4—Prednisone—hematologic cancer	0.00485	0.00685	CbGbCtD
Ethosuximide—CYP3A4—Irinotecan—hematologic cancer	0.0046	0.00649	CbGbCtD
Ethosuximide—CYP3A4—Vinblastine—hematologic cancer	0.00409	0.00577	CbGbCtD
Ethosuximide—CYP3A4—Vincristine—hematologic cancer	0.00402	0.00568	CbGbCtD
Ethosuximide—CYP3A4—Etoposide—hematologic cancer	0.00368	0.0052	CbGbCtD
Ethosuximide—CYP3A4—Dexamethasone—hematologic cancer	0.00303	0.00428	CbGbCtD
Ethosuximide—CYP3A4—Doxorubicin—hematologic cancer	0.00251	0.00355	CbGbCtD
Ethosuximide—Dermatitis—Thiotepa—hematologic cancer	8.19e-05	0.000326	CcSEcCtD
Ethosuximide—Diarrhoea—Alitretinoin—hematologic cancer	8.19e-05	0.000325	CcSEcCtD
Ethosuximide—Agranulocytosis—Methotrexate—hematologic cancer	8.19e-05	0.000325	CcSEcCtD
Ethosuximide—Headache—Thiotepa—hematologic cancer	8.15e-05	0.000324	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	8.14e-05	0.000324	CcSEcCtD
Ethosuximide—Decreased appetite—Etoposide—hematologic cancer	8.12e-05	0.000323	CcSEcCtD
Ethosuximide—Diarrhoea—Ifosfamide—hematologic cancer	8.09e-05	0.000322	CcSEcCtD
Ethosuximide—Pancytopenia—Doxorubicin—hematologic cancer	8.09e-05	0.000322	CcSEcCtD
Ethosuximide—Nausea—Vinorelbine—hematologic cancer	8.09e-05	0.000322	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Etoposide—hematologic cancer	8.07e-05	0.000321	CcSEcCtD
Ethosuximide—Asthenia—Mitoxantrone—hematologic cancer	8.06e-05	0.00032	CcSEcCtD
Ethosuximide—Asthenia—Irinotecan—hematologic cancer	8.06e-05	0.00032	CcSEcCtD
Ethosuximide—Fatigue—Etoposide—hematologic cancer	8.06e-05	0.00032	CcSEcCtD
Ethosuximide—Vomiting—Thalidomide—hematologic cancer	8e-05	0.000318	CcSEcCtD
Ethosuximide—Dizziness—Carmustine—hematologic cancer	7.99e-05	0.000318	CcSEcCtD
Ethosuximide—Rash—Thalidomide—hematologic cancer	7.93e-05	0.000315	CcSEcCtD
Ethosuximide—Dermatitis—Thalidomide—hematologic cancer	7.93e-05	0.000315	CcSEcCtD
Ethosuximide—Dizziness—Alitretinoin—hematologic cancer	7.92e-05	0.000315	CcSEcCtD
Ethosuximide—Diarrhoea—Vincristine—hematologic cancer	7.89e-05	0.000314	CcSEcCtD
Ethosuximide—Headache—Thalidomide—hematologic cancer	7.88e-05	0.000313	CcSEcCtD
Ethosuximide—Asthenia—Gemcitabine—hematologic cancer	7.85e-05	0.000312	CcSEcCtD
Ethosuximide—Haematuria—Epirubicin—hematologic cancer	7.83e-05	0.000311	CcSEcCtD
Ethosuximide—Dizziness—Ifosfamide—hematologic cancer	7.82e-05	0.000311	CcSEcCtD
Ethosuximide—Urinary tract disorder—Methotrexate—hematologic cancer	7.78e-05	0.000309	CcSEcCtD
Ethosuximide—Nausea—Thiotepa—hematologic cancer	7.73e-05	0.000307	CcSEcCtD
Ethosuximide—Urethral disorder—Methotrexate—hematologic cancer	7.72e-05	0.000307	CcSEcCtD
Ethosuximide—Weight decreased—Doxorubicin—hematologic cancer	7.71e-05	0.000306	CcSEcCtD
Ethosuximide—Diarrhoea—Mitoxantrone—hematologic cancer	7.69e-05	0.000305	CcSEcCtD
Ethosuximide—Diarrhoea—Irinotecan—hematologic cancer	7.69e-05	0.000305	CcSEcCtD
Ethosuximide—Vomiting—Carmustine—hematologic cancer	7.68e-05	0.000305	CcSEcCtD
Ethosuximide—Agranulocytosis—Epirubicin—hematologic cancer	7.66e-05	0.000305	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Etoposide—hematologic cancer	7.64e-05	0.000304	CcSEcCtD
Ethosuximide—Dizziness—Vincristine—hematologic cancer	7.63e-05	0.000303	CcSEcCtD
Ethosuximide—Rash—Carmustine—hematologic cancer	7.62e-05	0.000303	CcSEcCtD
Ethosuximide—Dermatitis—Carmustine—hematologic cancer	7.61e-05	0.000302	CcSEcCtD
Ethosuximide—Vomiting—Alitretinoin—hematologic cancer	7.61e-05	0.000302	CcSEcCtD
Ethosuximide—Drowsiness—Doxorubicin—hematologic cancer	7.6e-05	0.000302	CcSEcCtD
Ethosuximide—Headache—Carmustine—hematologic cancer	7.57e-05	0.000301	CcSEcCtD
Ethosuximide—Rash—Alitretinoin—hematologic cancer	7.55e-05	0.0003	CcSEcCtD
Ethosuximide—Nervous system disorder—Dexamethasone—hematologic cancer	7.54e-05	0.0003	CcSEcCtD
Ethosuximide—Nervous system disorder—Betamethasone—hematologic cancer	7.54e-05	0.0003	CcSEcCtD
Ethosuximide—Agitation—Prednisone—hematologic cancer	7.54e-05	0.0003	CcSEcCtD
Ethosuximide—Dermatitis—Alitretinoin—hematologic cancer	7.54e-05	0.0003	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	7.53e-05	0.000299	CcSEcCtD
Ethosuximide—Vomiting—Ifosfamide—hematologic cancer	7.52e-05	0.000299	CcSEcCtD
Ethosuximide—Hypersensitivity—Cisplatin—hematologic cancer	7.51e-05	0.000299	CcSEcCtD
Ethosuximide—Headache—Alitretinoin—hematologic cancer	7.5e-05	0.000298	CcSEcCtD
Ethosuximide—Diarrhoea—Gemcitabine—hematologic cancer	7.49e-05	0.000298	CcSEcCtD
Ethosuximide—Nausea—Thalidomide—hematologic cancer	7.47e-05	0.000297	CcSEcCtD
Ethosuximide—Rash—Ifosfamide—hematologic cancer	7.46e-05	0.000296	CcSEcCtD
Ethosuximide—Dermatitis—Ifosfamide—hematologic cancer	7.45e-05	0.000296	CcSEcCtD
Ethosuximide—Erythema multiforme—Methotrexate—hematologic cancer	7.45e-05	0.000296	CcSEcCtD
Ethosuximide—Dizziness—Irinotecan—hematologic cancer	7.43e-05	0.000295	CcSEcCtD
Ethosuximide—Urticaria—Etoposide—hematologic cancer	7.42e-05	0.000295	CcSEcCtD
Ethosuximide—Abdominal pain—Etoposide—hematologic cancer	7.39e-05	0.000294	CcSEcCtD
Ethosuximide—Eye disorder—Methotrexate—hematologic cancer	7.36e-05	0.000293	CcSEcCtD
Ethosuximide—Vomiting—Vincristine—hematologic cancer	7.33e-05	0.000291	CcSEcCtD
Ethosuximide—Anorexia—Dexamethasone—hematologic cancer	7.33e-05	0.000291	CcSEcCtD
Ethosuximide—Anorexia—Betamethasone—hematologic cancer	7.33e-05	0.000291	CcSEcCtD
Ethosuximide—Urticaria—Prednisolone—hematologic cancer	7.32e-05	0.000291	CcSEcCtD
Ethosuximide—Asthenia—Cisplatin—hematologic cancer	7.32e-05	0.000291	CcSEcCtD
Ethosuximide—Fatigue—Triamcinolone—hematologic cancer	7.31e-05	0.00029	CcSEcCtD
Ethosuximide—Urinary tract disorder—Epirubicin—hematologic cancer	7.28e-05	0.000289	CcSEcCtD
Ethosuximide—Rash—Vincristine—hematologic cancer	7.27e-05	0.000289	CcSEcCtD
Ethosuximide—Dermatitis—Vincristine—hematologic cancer	7.27e-05	0.000289	CcSEcCtD
Ethosuximide—Haematuria—Doxorubicin—hematologic cancer	7.24e-05	0.000288	CcSEcCtD
Ethosuximide—Connective tissue disorder—Epirubicin—hematologic cancer	7.24e-05	0.000288	CcSEcCtD
Ethosuximide—Urethral disorder—Epirubicin—hematologic cancer	7.23e-05	0.000287	CcSEcCtD
Ethosuximide—Headache—Vincristine—hematologic cancer	7.23e-05	0.000287	CcSEcCtD
Ethosuximide—Nausea—Carmustine—hematologic cancer	7.18e-05	0.000285	CcSEcCtD
Ethosuximide—Vomiting—Mitoxantrone—hematologic cancer	7.14e-05	0.000284	CcSEcCtD
Ethosuximide—Vomiting—Irinotecan—hematologic cancer	7.14e-05	0.000284	CcSEcCtD
Ethosuximide—Immune system disorder—Methotrexate—hematologic cancer	7.12e-05	0.000283	CcSEcCtD
Ethosuximide—Nausea—Alitretinoin—hematologic cancer	7.11e-05	0.000283	CcSEcCtD
Ethosuximide—Mediastinal disorder—Methotrexate—hematologic cancer	7.1e-05	0.000282	CcSEcCtD
Ethosuximide—Agranulocytosis—Doxorubicin—hematologic cancer	7.09e-05	0.000282	CcSEcCtD
Ethosuximide—Rash—Mitoxantrone—hematologic cancer	7.08e-05	0.000281	CcSEcCtD
Ethosuximide—Rash—Irinotecan—hematologic cancer	7.08e-05	0.000281	CcSEcCtD
Ethosuximide—Dermatitis—Irinotecan—hematologic cancer	7.08e-05	0.000281	CcSEcCtD
Ethosuximide—Dermatitis—Mitoxantrone—hematologic cancer	7.08e-05	0.000281	CcSEcCtD
Ethosuximide—Headache—Irinotecan—hematologic cancer	7.04e-05	0.00028	CcSEcCtD
Ethosuximide—Headache—Mitoxantrone—hematologic cancer	7.04e-05	0.00028	CcSEcCtD
Ethosuximide—Nausea—Ifosfamide—hematologic cancer	7.03e-05	0.000279	CcSEcCtD
Ethosuximide—Diarrhoea—Cisplatin—hematologic cancer	6.98e-05	0.000277	CcSEcCtD
Ethosuximide—Erythema multiforme—Epirubicin—hematologic cancer	6.97e-05	0.000277	CcSEcCtD
Ethosuximide—Vomiting—Gemcitabine—hematologic cancer	6.96e-05	0.000276	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.94e-05	0.000276	CcSEcCtD
Ethosuximide—Mental disorder—Methotrexate—hematologic cancer	6.9e-05	0.000274	CcSEcCtD
Ethosuximide—Rash—Gemcitabine—hematologic cancer	6.9e-05	0.000274	CcSEcCtD
Ethosuximide—Dermatitis—Gemcitabine—hematologic cancer	6.89e-05	0.000274	CcSEcCtD
Ethosuximide—Eye disorder—Epirubicin—hematologic cancer	6.89e-05	0.000274	CcSEcCtD
Ethosuximide—Hypersensitivity—Etoposide—hematologic cancer	6.88e-05	0.000274	CcSEcCtD
Ethosuximide—Malnutrition—Methotrexate—hematologic cancer	6.86e-05	0.000273	CcSEcCtD
Ethosuximide—Headache—Gemcitabine—hematologic cancer	6.85e-05	0.000272	CcSEcCtD
Ethosuximide—Nausea—Vincristine—hematologic cancer	6.85e-05	0.000272	CcSEcCtD
Ethosuximide—Hypersensitivity—Prednisolone—hematologic cancer	6.79e-05	0.00027	CcSEcCtD
Ethosuximide—Urinary tract disorder—Doxorubicin—hematologic cancer	6.74e-05	0.000268	CcSEcCtD
Ethosuximide—Urticaria—Triamcinolone—hematologic cancer	6.73e-05	0.000268	CcSEcCtD
Ethosuximide—Asthenia—Etoposide—hematologic cancer	6.7e-05	0.000266	CcSEcCtD
Ethosuximide—Connective tissue disorder—Doxorubicin—hematologic cancer	6.7e-05	0.000266	CcSEcCtD
Ethosuximide—Urethral disorder—Doxorubicin—hematologic cancer	6.69e-05	0.000266	CcSEcCtD
Ethosuximide—Decreased appetite—Betamethasone—hematologic cancer	6.68e-05	0.000266	CcSEcCtD
Ethosuximide—Decreased appetite—Dexamethasone—hematologic cancer	6.68e-05	0.000266	CcSEcCtD
Ethosuximide—Nausea—Mitoxantrone—hematologic cancer	6.67e-05	0.000265	CcSEcCtD
Ethosuximide—Nausea—Irinotecan—hematologic cancer	6.67e-05	0.000265	CcSEcCtD
Ethosuximide—Immune system disorder—Epirubicin—hematologic cancer	6.66e-05	0.000265	CcSEcCtD
Ethosuximide—Mediastinal disorder—Epirubicin—hematologic cancer	6.64e-05	0.000264	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.64e-05	0.000264	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.64e-05	0.000264	CcSEcCtD
Ethosuximide—Fatigue—Dexamethasone—hematologic cancer	6.63e-05	0.000263	CcSEcCtD
Ethosuximide—Fatigue—Betamethasone—hematologic cancer	6.63e-05	0.000263	CcSEcCtD
Ethosuximide—Nervous system disorder—Prednisone—hematologic cancer	6.57e-05	0.000261	CcSEcCtD
Ethosuximide—Skin disorder—Prednisone—hematologic cancer	6.5e-05	0.000259	CcSEcCtD
Ethosuximide—Nausea—Gemcitabine—hematologic cancer	6.5e-05	0.000258	CcSEcCtD
Ethosuximide—Vomiting—Cisplatin—hematologic cancer	6.48e-05	0.000258	CcSEcCtD
Ethosuximide—Mental disorder—Epirubicin—hematologic cancer	6.46e-05	0.000257	CcSEcCtD
Ethosuximide—Erythema multiforme—Doxorubicin—hematologic cancer	6.45e-05	0.000256	CcSEcCtD
Ethosuximide—Rash—Cisplatin—hematologic cancer	6.43e-05	0.000256	CcSEcCtD
Ethosuximide—Dermatitis—Cisplatin—hematologic cancer	6.42e-05	0.000255	CcSEcCtD
Ethosuximide—Malnutrition—Epirubicin—hematologic cancer	6.42e-05	0.000255	CcSEcCtD
Ethosuximide—Diarrhoea—Etoposide—hematologic cancer	6.39e-05	0.000254	CcSEcCtD
Ethosuximide—Anorexia—Prednisone—hematologic cancer	6.38e-05	0.000254	CcSEcCtD
Ethosuximide—Eye disorder—Doxorubicin—hematologic cancer	6.37e-05	0.000253	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.29e-05	0.00025	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Betamethasone—hematologic cancer	6.29e-05	0.00025	CcSEcCtD
Ethosuximide—Hypersensitivity—Triamcinolone—hematologic cancer	6.24e-05	0.000248	CcSEcCtD
Ethosuximide—Dizziness—Etoposide—hematologic cancer	6.18e-05	0.000246	CcSEcCtD
Ethosuximide—Muscle spasms—Epirubicin—hematologic cancer	6.17e-05	0.000245	CcSEcCtD
Ethosuximide—Immune system disorder—Doxorubicin—hematologic cancer	6.16e-05	0.000245	CcSEcCtD
Ethosuximide—Mediastinal disorder—Doxorubicin—hematologic cancer	6.15e-05	0.000244	CcSEcCtD
Ethosuximide—Leukopenia—Methotrexate—hematologic cancer	6.14e-05	0.000244	CcSEcCtD
Ethosuximide—Urticaria—Dexamethasone—hematologic cancer	6.11e-05	0.000243	CcSEcCtD
Ethosuximide—Urticaria—Betamethasone—hematologic cancer	6.11e-05	0.000243	CcSEcCtD
Ethosuximide—Dizziness—Prednisolone—hematologic cancer	6.09e-05	0.000242	CcSEcCtD
Ethosuximide—Asthenia—Triamcinolone—hematologic cancer	6.08e-05	0.000242	CcSEcCtD
Ethosuximide—Abdominal pain—Betamethasone—hematologic cancer	6.08e-05	0.000242	CcSEcCtD
Ethosuximide—Abdominal pain—Dexamethasone—hematologic cancer	6.08e-05	0.000242	CcSEcCtD
Ethosuximide—Nausea—Cisplatin—hematologic cancer	6.06e-05	0.000241	CcSEcCtD
Ethosuximide—Mental disorder—Doxorubicin—hematologic cancer	5.98e-05	0.000237	CcSEcCtD
Ethosuximide—Vomiting—Etoposide—hematologic cancer	5.94e-05	0.000236	CcSEcCtD
Ethosuximide—Malnutrition—Doxorubicin—hematologic cancer	5.94e-05	0.000236	CcSEcCtD
Ethosuximide—Agitation—Epirubicin—hematologic cancer	5.9e-05	0.000234	CcSEcCtD
Ethosuximide—Rash—Etoposide—hematologic cancer	5.89e-05	0.000234	CcSEcCtD
Ethosuximide—Dermatitis—Etoposide—hematologic cancer	5.89e-05	0.000234	CcSEcCtD
Ethosuximide—Headache—Etoposide—hematologic cancer	5.85e-05	0.000233	CcSEcCtD
Ethosuximide—Decreased appetite—Prednisone—hematologic cancer	5.82e-05	0.000231	CcSEcCtD
Ethosuximide—Rash—Prednisolone—hematologic cancer	5.81e-05	0.000231	CcSEcCtD
Ethosuximide—Dermatitis—Prednisolone—hematologic cancer	5.81e-05	0.000231	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.8e-05	0.00023	CcSEcCtD
Ethosuximide—Fatigue—Prednisone—hematologic cancer	5.77e-05	0.000229	CcSEcCtD
Ethosuximide—Headache—Prednisolone—hematologic cancer	5.77e-05	0.000229	CcSEcCtD
Ethosuximide—Leukopenia—Epirubicin—hematologic cancer	5.74e-05	0.000228	CcSEcCtD
Ethosuximide—Muscle spasms—Doxorubicin—hematologic cancer	5.71e-05	0.000227	CcSEcCtD
Ethosuximide—Dizziness—Triamcinolone—hematologic cancer	5.6e-05	0.000223	CcSEcCtD
Ethosuximide—Nausea—Etoposide—hematologic cancer	5.55e-05	0.000221	CcSEcCtD
Ethosuximide—Asthenia—Dexamethasone—hematologic cancer	5.52e-05	0.000219	CcSEcCtD
Ethosuximide—Asthenia—Betamethasone—hematologic cancer	5.52e-05	0.000219	CcSEcCtD
Ethosuximide—Nervous system disorder—Methotrexate—hematologic cancer	5.49e-05	0.000218	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Prednisone—hematologic cancer	5.48e-05	0.000218	CcSEcCtD
Ethosuximide—Nausea—Prednisolone—hematologic cancer	5.47e-05	0.000218	CcSEcCtD
Ethosuximide—Agitation—Doxorubicin—hematologic cancer	5.46e-05	0.000217	CcSEcCtD
Ethosuximide—Skin disorder—Methotrexate—hematologic cancer	5.44e-05	0.000216	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.43e-05	0.000216	CcSEcCtD
Ethosuximide—Vomiting—Triamcinolone—hematologic cancer	5.39e-05	0.000214	CcSEcCtD
Ethosuximide—Rash—Triamcinolone—hematologic cancer	5.34e-05	0.000212	CcSEcCtD
Ethosuximide—Dermatitis—Triamcinolone—hematologic cancer	5.34e-05	0.000212	CcSEcCtD
Ethosuximide—Anorexia—Methotrexate—hematologic cancer	5.33e-05	0.000212	CcSEcCtD
Ethosuximide—Urticaria—Prednisone—hematologic cancer	5.32e-05	0.000211	CcSEcCtD
Ethosuximide—Leukopenia—Doxorubicin—hematologic cancer	5.32e-05	0.000211	CcSEcCtD
Ethosuximide—Headache—Triamcinolone—hematologic cancer	5.31e-05	0.000211	CcSEcCtD
Ethosuximide—Abdominal pain—Prednisone—hematologic cancer	5.29e-05	0.00021	CcSEcCtD
Ethosuximide—Diarrhoea—Dexamethasone—hematologic cancer	5.26e-05	0.000209	CcSEcCtD
Ethosuximide—Diarrhoea—Betamethasone—hematologic cancer	5.26e-05	0.000209	CcSEcCtD
Ethosuximide—Nervous system disorder—Epirubicin—hematologic cancer	5.14e-05	0.000204	CcSEcCtD
Ethosuximide—Skin disorder—Epirubicin—hematologic cancer	5.09e-05	0.000202	CcSEcCtD
Ethosuximide—Dizziness—Dexamethasone—hematologic cancer	5.09e-05	0.000202	CcSEcCtD
Ethosuximide—Dizziness—Betamethasone—hematologic cancer	5.09e-05	0.000202	CcSEcCtD
Ethosuximide—Nausea—Triamcinolone—hematologic cancer	5.03e-05	0.0002	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.02e-05	0.0002	CcSEcCtD
Ethosuximide—Anorexia—Epirubicin—hematologic cancer	4.99e-05	0.000198	CcSEcCtD
Ethosuximide—Somnolence—Methotrexate—hematologic cancer	4.98e-05	0.000198	CcSEcCtD
Ethosuximide—Hypersensitivity—Prednisone—hematologic cancer	4.93e-05	0.000196	CcSEcCtD
Ethosuximide—Vomiting—Betamethasone—hematologic cancer	4.89e-05	0.000194	CcSEcCtD
Ethosuximide—Vomiting—Dexamethasone—hematologic cancer	4.89e-05	0.000194	CcSEcCtD
Ethosuximide—Decreased appetite—Methotrexate—hematologic cancer	4.87e-05	0.000193	CcSEcCtD
Ethosuximide—Rash—Betamethasone—hematologic cancer	4.85e-05	0.000193	CcSEcCtD
Ethosuximide—Rash—Dexamethasone—hematologic cancer	4.85e-05	0.000193	CcSEcCtD
Ethosuximide—Dermatitis—Betamethasone—hematologic cancer	4.84e-05	0.000193	CcSEcCtD
Ethosuximide—Dermatitis—Dexamethasone—hematologic cancer	4.84e-05	0.000193	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.83e-05	0.000192	CcSEcCtD
Ethosuximide—Fatigue—Methotrexate—hematologic cancer	4.83e-05	0.000192	CcSEcCtD
Ethosuximide—Headache—Betamethasone—hematologic cancer	4.82e-05	0.000191	CcSEcCtD
Ethosuximide—Headache—Dexamethasone—hematologic cancer	4.82e-05	0.000191	CcSEcCtD
Ethosuximide—Asthenia—Prednisone—hematologic cancer	4.8e-05	0.000191	CcSEcCtD
Ethosuximide—Nervous system disorder—Doxorubicin—hematologic cancer	4.75e-05	0.000189	CcSEcCtD
Ethosuximide—Skin disorder—Doxorubicin—hematologic cancer	4.71e-05	0.000187	CcSEcCtD
Ethosuximide—Somnolence—Epirubicin—hematologic cancer	4.66e-05	0.000185	CcSEcCtD
Ethosuximide—Anorexia—Doxorubicin—hematologic cancer	4.62e-05	0.000184	CcSEcCtD
Ethosuximide—Diarrhoea—Prednisone—hematologic cancer	4.58e-05	0.000182	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Methotrexate—hematologic cancer	4.58e-05	0.000182	CcSEcCtD
Ethosuximide—Nausea—Betamethasone—hematologic cancer	4.57e-05	0.000182	CcSEcCtD
Ethosuximide—Nausea—Dexamethasone—hematologic cancer	4.57e-05	0.000182	CcSEcCtD
Ethosuximide—Decreased appetite—Epirubicin—hematologic cancer	4.55e-05	0.000181	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.52e-05	0.00018	CcSEcCtD
Ethosuximide—Fatigue—Epirubicin—hematologic cancer	4.52e-05	0.000179	CcSEcCtD
Ethosuximide—Urticaria—Methotrexate—hematologic cancer	4.45e-05	0.000177	CcSEcCtD
Ethosuximide—Dizziness—Prednisone—hematologic cancer	4.43e-05	0.000176	CcSEcCtD
Ethosuximide—Abdominal pain—Methotrexate—hematologic cancer	4.42e-05	0.000176	CcSEcCtD
Ethosuximide—Somnolence—Doxorubicin—hematologic cancer	4.31e-05	0.000171	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Epirubicin—hematologic cancer	4.28e-05	0.00017	CcSEcCtD
Ethosuximide—Vomiting—Prednisone—hematologic cancer	4.26e-05	0.000169	CcSEcCtD
Ethosuximide—Rash—Prednisone—hematologic cancer	4.22e-05	0.000168	CcSEcCtD
Ethosuximide—Dermatitis—Prednisone—hematologic cancer	4.22e-05	0.000168	CcSEcCtD
Ethosuximide—Decreased appetite—Doxorubicin—hematologic cancer	4.21e-05	0.000167	CcSEcCtD
Ethosuximide—Headache—Prednisone—hematologic cancer	4.2e-05	0.000167	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.18e-05	0.000166	CcSEcCtD
Ethosuximide—Fatigue—Doxorubicin—hematologic cancer	4.18e-05	0.000166	CcSEcCtD
Ethosuximide—Urticaria—Epirubicin—hematologic cancer	4.16e-05	0.000165	CcSEcCtD
Ethosuximide—Abdominal pain—Epirubicin—hematologic cancer	4.14e-05	0.000165	CcSEcCtD
Ethosuximide—Hypersensitivity—Methotrexate—hematologic cancer	4.12e-05	0.000164	CcSEcCtD
Ethosuximide—Asthenia—Methotrexate—hematologic cancer	4.02e-05	0.00016	CcSEcCtD
Ethosuximide—Nausea—Prednisone—hematologic cancer	3.98e-05	0.000158	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.96e-05	0.000157	CcSEcCtD
Ethosuximide—Hypersensitivity—Epirubicin—hematologic cancer	3.86e-05	0.000153	CcSEcCtD
Ethosuximide—Urticaria—Doxorubicin—hematologic cancer	3.85e-05	0.000153	CcSEcCtD
Ethosuximide—Abdominal pain—Doxorubicin—hematologic cancer	3.83e-05	0.000152	CcSEcCtD
Ethosuximide—Diarrhoea—Methotrexate—hematologic cancer	3.83e-05	0.000152	CcSEcCtD
Ethosuximide—Asthenia—Epirubicin—hematologic cancer	3.76e-05	0.000149	CcSEcCtD
Ethosuximide—Dizziness—Methotrexate—hematologic cancer	3.7e-05	0.000147	CcSEcCtD
Ethosuximide—Diarrhoea—Epirubicin—hematologic cancer	3.58e-05	0.000142	CcSEcCtD
Ethosuximide—Hypersensitivity—Doxorubicin—hematologic cancer	3.57e-05	0.000142	CcSEcCtD
Ethosuximide—Vomiting—Methotrexate—hematologic cancer	3.56e-05	0.000141	CcSEcCtD
Ethosuximide—Rash—Methotrexate—hematologic cancer	3.53e-05	0.00014	CcSEcCtD
Ethosuximide—Dermatitis—Methotrexate—hematologic cancer	3.53e-05	0.00014	CcSEcCtD
Ethosuximide—Headache—Methotrexate—hematologic cancer	3.51e-05	0.000139	CcSEcCtD
Ethosuximide—Asthenia—Doxorubicin—hematologic cancer	3.48e-05	0.000138	CcSEcCtD
Ethosuximide—Dizziness—Epirubicin—hematologic cancer	3.46e-05	0.000138	CcSEcCtD
Ethosuximide—Vomiting—Epirubicin—hematologic cancer	3.33e-05	0.000132	CcSEcCtD
Ethosuximide—Nausea—Methotrexate—hematologic cancer	3.32e-05	0.000132	CcSEcCtD
Ethosuximide—Diarrhoea—Doxorubicin—hematologic cancer	3.32e-05	0.000132	CcSEcCtD
Ethosuximide—Rash—Epirubicin—hematologic cancer	3.3e-05	0.000131	CcSEcCtD
Ethosuximide—Dermatitis—Epirubicin—hematologic cancer	3.3e-05	0.000131	CcSEcCtD
Ethosuximide—Headache—Epirubicin—hematologic cancer	3.28e-05	0.00013	CcSEcCtD
Ethosuximide—Dizziness—Doxorubicin—hematologic cancer	3.2e-05	0.000127	CcSEcCtD
Ethosuximide—Nausea—Epirubicin—hematologic cancer	3.11e-05	0.000124	CcSEcCtD
Ethosuximide—Vomiting—Doxorubicin—hematologic cancer	3.08e-05	0.000122	CcSEcCtD
Ethosuximide—Rash—Doxorubicin—hematologic cancer	3.06e-05	0.000121	CcSEcCtD
Ethosuximide—Dermatitis—Doxorubicin—hematologic cancer	3.05e-05	0.000121	CcSEcCtD
Ethosuximide—Headache—Doxorubicin—hematologic cancer	3.04e-05	0.000121	CcSEcCtD
Ethosuximide—Nausea—Doxorubicin—hematologic cancer	2.88e-05	0.000114	CcSEcCtD
Ethosuximide—CYP3A5—Metabolism—SMPD3—hematologic cancer	2.6e-05	0.000641	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—SRC—hematologic cancer	2.57e-05	0.000635	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—HRAS—hematologic cancer	2.54e-05	0.000626	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GBA—hematologic cancer	2.53e-05	0.000624	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC35B2—hematologic cancer	2.53e-05	0.000624	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—VEGFA—hematologic cancer	2.51e-05	0.000618	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	2.49e-05	0.000613	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—STAT3—hematologic cancer	2.48e-05	0.000612	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NRAS—hematologic cancer	2.47e-05	0.000611	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYCS—hematologic cancer	2.47e-05	0.000609	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HSP90AA1—hematologic cancer	2.45e-05	0.000605	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—IL6—hematologic cancer	2.43e-05	0.000599	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MAPK3—hematologic cancer	2.37e-05	0.000585	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTAP—hematologic cancer	2.31e-05	0.000571	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TGFB1—hematologic cancer	2.3e-05	0.000567	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ASNS—hematologic cancer	2.27e-05	0.000561	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—B3GAT1—hematologic cancer	2.27e-05	0.000561	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—DCK—hematologic cancer	2.27e-05	0.000561	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ASNS—hematologic cancer	2.27e-05	0.00056	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—B3GAT1—hematologic cancer	2.27e-05	0.00056	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—DCK—hematologic cancer	2.27e-05	0.00056	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTP1—hematologic cancer	2.18e-05	0.000537	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HDC—hematologic cancer	2.16e-05	0.000532	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HDC—hematologic cancer	2.15e-05	0.000531	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TNF—hematologic cancer	2.15e-05	0.00053	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—KRAS—hematologic cancer	2.13e-05	0.000526	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—FHL2—hematologic cancer	2.06e-05	0.000509	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ABCB1—hematologic cancer	2.06e-05	0.000508	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AGRN—hematologic cancer	2.02e-05	0.000499	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTM1—hematologic cancer	2e-05	0.000493	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NCOR1—hematologic cancer	2e-05	0.000493	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CDA—hematologic cancer	1.97e-05	0.000487	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CDA—hematologic cancer	1.97e-05	0.000486	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—IDH2—hematologic cancer	1.92e-05	0.000473	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HMMR—hematologic cancer	1.92e-05	0.000473	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PC—hematologic cancer	1.9e-05	0.000468	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PC—hematologic cancer	1.89e-05	0.000467	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC35B2—hematologic cancer	1.83e-05	0.000452	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GBA—hematologic cancer	1.83e-05	0.000452	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC35B2—hematologic cancer	1.83e-05	0.000451	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GBA—hematologic cancer	1.83e-05	0.000451	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—HRAS—hematologic cancer	1.81e-05	0.000447	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ARNTL—hematologic cancer	1.8e-05	0.000445	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—MTHFR—hematologic cancer	1.77e-05	0.000436	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CA9—hematologic cancer	1.75e-05	0.000433	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ACP5—hematologic cancer	1.75e-05	0.000433	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—IL6—hematologic cancer	1.73e-05	0.000428	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NCOR2—hematologic cancer	1.73e-05	0.000427	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.72e-05	0.000425	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.7e-05	0.000419	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTAP—hematologic cancer	1.68e-05	0.000414	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTAP—hematologic cancer	1.67e-05	0.000413	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—IDH1—hematologic cancer	1.65e-05	0.000407	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCC3—hematologic cancer	1.63e-05	0.000402	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TXN—hematologic cancer	1.63e-05	0.000402	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTO1—hematologic cancer	1.63e-05	0.000402	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT1—hematologic cancer	1.6e-05	0.000394	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SPHK1—hematologic cancer	1.6e-05	0.000394	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.58e-05	0.000391	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.56e-05	0.000385	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—UGT1A1—hematologic cancer	1.53e-05	0.000378	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—FHL2—hematologic cancer	1.49e-05	0.000369	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC22A1—hematologic cancer	1.49e-05	0.000368	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CRABP1—hematologic cancer	1.49e-05	0.000368	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—FHL2—hematologic cancer	1.49e-05	0.000368	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CG—hematologic cancer	1.48e-05	0.000366	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AGRN—hematologic cancer	1.47e-05	0.000362	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AGRN—hematologic cancer	1.46e-05	0.000361	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALOX5—hematologic cancer	1.45e-05	0.000359	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NUP98—hematologic cancer	1.41e-05	0.000347	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HMMR—hematologic cancer	1.39e-05	0.000343	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—IDH2—hematologic cancer	1.39e-05	0.000343	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HMMR—hematologic cancer	1.39e-05	0.000342	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—IDH2—hematologic cancer	1.39e-05	0.000342	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CREBBP—hematologic cancer	1.38e-05	0.00034	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADCY7—hematologic cancer	1.37e-05	0.000337	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NCOA3—hematologic cancer	1.37e-05	0.000337	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NUP214—hematologic cancer	1.36e-05	0.000335	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCG2—hematologic cancer	1.33e-05	0.000328	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTR—hematologic cancer	1.33e-05	0.000328	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GMPS—hematologic cancer	1.32e-05	0.000326	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PHYH—hematologic cancer	1.32e-05	0.000326	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—FTCD—hematologic cancer	1.32e-05	0.000326	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ARNTL—hematologic cancer	1.31e-05	0.000322	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CD—hematologic cancer	1.31e-05	0.000322	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ENO2—hematologic cancer	1.3e-05	0.000322	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ARNTL—hematologic cancer	1.3e-05	0.000322	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALB—hematologic cancer	1.29e-05	0.000318	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ACP5—hematologic cancer	1.27e-05	0.000314	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CA9—hematologic cancer	1.27e-05	0.000314	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ACP5—hematologic cancer	1.27e-05	0.000313	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CA9—hematologic cancer	1.27e-05	0.000313	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTT1—hematologic cancer	1.26e-05	0.000312	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOR2—hematologic cancer	1.25e-05	0.000309	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOR2—hematologic cancer	1.25e-05	0.000309	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SDC1—hematologic cancer	1.24e-05	0.000305	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3R1—hematologic cancer	1.23e-05	0.000304	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.21e-05	0.000298	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—IDH1—hematologic cancer	1.19e-05	0.000295	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—IDH1—hematologic cancer	1.19e-05	0.000294	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TXN—hematologic cancer	1.18e-05	0.000291	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTO1—hematologic cancer	1.18e-05	0.000291	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCC3—hematologic cancer	1.18e-05	0.000291	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TXN—hematologic cancer	1.18e-05	0.000291	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTO1—hematologic cancer	1.18e-05	0.000291	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCC3—hematologic cancer	1.18e-05	0.000291	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SPHK1—hematologic cancer	1.16e-05	0.000285	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SPHK1—hematologic cancer	1.15e-05	0.000285	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CB—hematologic cancer	1.14e-05	0.000281	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—UGT1A1—hematologic cancer	1.11e-05	0.000274	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—UGT1A1—hematologic cancer	1.11e-05	0.000273	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CRABP1—hematologic cancer	1.08e-05	0.000267	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC22A1—hematologic cancer	1.08e-05	0.000267	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CRABP1—hematologic cancer	1.08e-05	0.000266	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC22A1—hematologic cancer	1.08e-05	0.000266	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.06e-05	0.00026	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—DCK—hematologic cancer	1.06e-05	0.00026	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ASNS—hematologic cancer	1.06e-05	0.00026	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALOX5—hematologic cancer	1.05e-05	0.00026	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NQO1—hematologic cancer	1.05e-05	0.000259	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CD44—hematologic cancer	1.05e-05	0.000259	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.05e-05	0.000259	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NUP98—hematologic cancer	1.02e-05	0.000252	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NUP98—hematologic cancer	1.02e-05	0.000251	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HDC—hematologic cancer	1e-05	0.000247	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYCS—hematologic cancer	9.94e-06	0.000245	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOA3—hematologic cancer	9.9e-06	0.000244	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADCY7—hematologic cancer	9.9e-06	0.000244	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	9.88e-06	0.000244	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADCY7—hematologic cancer	9.88e-06	0.000244	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOA3—hematologic cancer	9.88e-06	0.000244	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTEN—hematologic cancer	9.83e-06	0.000243	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NUP214—hematologic cancer	9.83e-06	0.000243	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NUP214—hematologic cancer	9.81e-06	0.000242	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCG2—hematologic cancer	9.63e-06	0.000238	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTR—hematologic cancer	9.63e-06	0.000238	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCG2—hematologic cancer	9.61e-06	0.000237	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTR—hematologic cancer	9.61e-06	0.000237	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ENO2—hematologic cancer	9.44e-06	0.000233	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ENO2—hematologic cancer	9.42e-06	0.000233	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—EP300—hematologic cancer	9.38e-06	0.000231	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTT1—hematologic cancer	9.16e-06	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CDA—hematologic cancer	9.15e-06	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTT1—hematologic cancer	9.14e-06	0.000226	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SDC1—hematologic cancer	8.95e-06	0.000221	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SDC1—hematologic cancer	8.93e-06	0.00022	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PC—hematologic cancer	8.81e-06	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTP1—hematologic cancer	8.77e-06	0.000216	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GBA—hematologic cancer	8.51e-06	0.00021	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.51e-06	0.00021	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCB1—hematologic cancer	8.3e-06	0.000205	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTM1—hematologic cancer	8.06e-06	0.000199	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NCOR1—hematologic cancer	8.06e-06	0.000199	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTAP—hematologic cancer	7.78e-06	0.000192	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NQO1—hematologic cancer	7.61e-06	0.000188	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CD44—hematologic cancer	7.61e-06	0.000188	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CD44—hematologic cancer	7.6e-06	0.000187	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NQO1—hematologic cancer	7.6e-06	0.000187	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYCS—hematologic cancer	7.2e-06	0.000178	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYCS—hematologic cancer	7.19e-06	0.000177	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	7.16e-06	0.000177	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	7.14e-06	0.000176	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTHFR—hematologic cancer	7.12e-06	0.000176	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CA—hematologic cancer	6.94e-06	0.000171	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—FHL2—hematologic cancer	6.93e-06	0.000171	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AGRN—hematologic cancer	6.8e-06	0.000168	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMMR—hematologic cancer	6.45e-06	0.000159	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—IDH2—hematologic cancer	6.45e-06	0.000159	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTP1—hematologic cancer	6.35e-06	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTP1—hematologic cancer	6.34e-06	0.000156	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.06e-06	0.00015	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCB1—hematologic cancer	6.01e-06	0.000148	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCB1—hematologic cancer	6e-06	0.000148	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CG—hematologic cancer	5.98e-06	0.000148	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ACP5—hematologic cancer	5.9e-06	0.000145	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CA9—hematologic cancer	5.9e-06	0.000145	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOR1—hematologic cancer	5.83e-06	0.000144	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTM1—hematologic cancer	5.83e-06	0.000144	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTM1—hematologic cancer	5.82e-06	0.000144	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOR1—hematologic cancer	5.82e-06	0.000144	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.82e-06	0.000144	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKT1—hematologic cancer	5.67e-06	0.00014	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CREBBP—hematologic cancer	5.55e-06	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—IDH1—hematologic cancer	5.54e-06	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.48e-06	0.000135	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.48e-06	0.000135	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TXN—hematologic cancer	5.48e-06	0.000135	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.36e-06	0.000132	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CD—hematologic cancer	5.26e-06	0.00013	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALB—hematologic cancer	5.19e-06	0.000128	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTHFR—hematologic cancer	5.16e-06	0.000127	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.15e-06	0.000127	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTHFR—hematologic cancer	5.15e-06	0.000127	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.01e-06	0.000124	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.01e-06	0.000124	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3R1—hematologic cancer	4.97e-06	0.000123	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.89e-06	0.000121	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NUP98—hematologic cancer	4.73e-06	0.000117	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.59e-06	0.000113	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.59e-06	0.000113	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CB—hematologic cancer	4.58e-06	0.000113	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NUP214—hematologic cancer	4.56e-06	0.000113	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTR—hematologic cancer	4.47e-06	0.00011	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.47e-06	0.00011	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ENO2—hematologic cancer	4.38e-06	0.000108	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CG—hematologic cancer	4.33e-06	0.000107	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CG—hematologic cancer	4.32e-06	0.000107	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.25e-06	0.000105	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SDC1—hematologic cancer	4.15e-06	0.000102	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CREBBP—hematologic cancer	4.02e-06	9.91e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CREBBP—hematologic cancer	4.01e-06	9.89e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTEN—hematologic cancer	3.96e-06	9.77e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CD—hematologic cancer	3.81e-06	9.4e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CD—hematologic cancer	3.8e-06	9.38e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—EP300—hematologic cancer	3.78e-06	9.32e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALB—hematologic cancer	3.76e-06	9.28e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALB—hematologic cancer	3.75e-06	9.26e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3R1—hematologic cancer	3.6e-06	8.87e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3R1—hematologic cancer	3.59e-06	8.86e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CD44—hematologic cancer	3.53e-06	8.71e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NQO1—hematologic cancer	3.53e-06	8.71e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYCS—hematologic cancer	3.34e-06	8.25e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.32e-06	8.19e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.32e-06	8.19e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CB—hematologic cancer	3.31e-06	8.17e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.95e-06	7.27e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTEN—hematologic cancer	2.87e-06	7.08e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTEN—hematologic cancer	2.86e-06	7.06e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.79e-06	6.89e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.79e-06	6.88e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—EP300—hematologic cancer	2.74e-06	6.75e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—EP300—hematologic cancer	2.73e-06	6.74e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.71e-06	6.68e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.71e-06	6.68e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.39e-06	5.9e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKT1—hematologic cancer	2.28e-06	5.63e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.02e-06	4.99e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.02e-06	4.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.01e-06	4.96e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.86e-06	4.6e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.77e-06	4.36e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALB—hematologic cancer	1.74e-06	4.3e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.67e-06	4.12e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKT1—hematologic cancer	1.65e-06	4.08e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKT1—hematologic cancer	1.65e-06	4.07e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.54e-06	3.8e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTEN—hematologic cancer	1.33e-06	3.28e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—EP300—hematologic cancer	1.27e-06	3.13e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.39e-07	2.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKT1—hematologic cancer	7.67e-07	1.89e-05	CbGpPWpGaD
